Corvus Pharma (CRVS) files mixed shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Form S-3ASR Corvus Pharmaceuticals,
March 13, 2026 8:02 AM EDTTABLE OF CONTENTS As filed with the Securities and Exchange Commission on March 13, 2026 Registration No. 333- UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549... More



